St. Louis Business Journal by Evan Binns, Reporter
KV Pharmaceutical paid two top executives nearly $379,000 in performance bonuses and stock options amid questions about the beleaguered drug company’s ability to survive.
On March 27, at meeting of KV’s board of directors, the company approved a $130,000 cash bonus for President and Chief Executive Greg Divis for fiscal 2012 performance, according to documents filed with the Securities and Exchange Commission.
Divis receives an annual base salary of $520,000, according to the company’s most recent proxy, filed in July 2011.
Chief Financial Officer Tom McHugh received a cash bonus of $65,000 for the company’s fiscal 2012 performance.
